RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioAesthetics Corporation today announced that it has significantly surpassed its Series A funding goal of $2.5 million, further advancing its inaugural ...
Long-term outcome of DCIS patients: p53 as a biomarker of ipsilateral recurrence. Background: Preoperative assessment of the nipple-areolar complex (NAC) is invaluable when considering nipple-sparing ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioAesthetics Corporation today announced an additional clinical study for the BioAesthetics® NACgraft™ Acellular Allograft that will investigate its ...
D. Scott Lind, M.D., F.A.C.S.; Barbara L. Smith, M.D., Ph.D., F.A.C.S.; Wiley W. Souba, M.D., Sc.D., F.A.C.S. Terminal duct excision is the procedure of choice in the ...
A review of 1026 consecutive nipple-sparing mastectomies with separately submitted subareolar tissue biopsy specimens confirmed the value of subareolar intraoperative frozen section evaluations for ...
Pathologic features, clinical outcomes, and treatment patterns of early-stage triple-negative (TN) breast cancer in an Australian population. Background: Important preoperative information to decide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback